Mechanisms and clinical advancements of cell-based immunotherapies in non-small cell lung cancer: an integrated perspective
Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide, with only modest improvements in survival despite advances in conventional therapies. Cell-based immunotherapy, which utilizes ex vivo expanded or genetic…